SINOCHEM INTERNATIONAL(SH:600500)2021-04-29 16:00Financial Performance - Operating revenue rose by 43.52% to CNY 17,388,396,727.61 year-on-year[11] - Net profit attributable to shareholders surged by 1,779.21% to CNY 309,629,789.52 compared to the same period last year[11] - Basic earnings per share reached CNY 0.1143, up 1,773.77% from the previous year[13] - Revenue for the period was ¥17,388,396,727.61, representing a 43.52% increase compared to ¥12,115,321,290.17 in the same period last year[23] - Operating profit for Q1 2021 was ¥1,185,717,097.97, significantly higher than ¥579,866,006.18 in Q1 2020, representing an increase of about 104.4%[44] - Net profit for Q1 2021 was ¥942,404,133.29, compared to ¥525,182,808.92 in Q1 2020, indicating an increase of about 79.4%[44] Assets and Liabilities - Total assets increased by 26.90% to CNY 70,983,924,507.43 compared to the end of the previous year[11] - Current assets rose to ¥38,016,371,167.75 from ¥24,493,902,911.46, marking an increase of about 55.1%[30] - Total liabilities reached ¥42,134,369,133.49, up from ¥27,936,609,995.53, indicating an increase of around 50.7%[33] - The company's total liabilities increased significantly, with long-term borrowings rising by 108.06% to ¥5,612,561,046.69 from ¥2,697,591,482.37, reflecting increased funding for construction projects[23] - Total liabilities rose to ¥11,044,941,221.18 in Q1 2021, up from ¥8,326,420,035.41 in Q1 2020, marking an increase of around 32.7%[41] Cash Flow - Net cash flow from operating activities was negative at CNY -2,548,549,483.01, worsening from CNY -1,102,861,235.96 in the previous year[11] - The net cash flow from operating activities was -¥2,548,549,483.01, a decrease compared to -¥1,102,861,235.96 in the previous year[23] - Cash inflow from investment activities totaled 3,074,832,405.54 RMB, an increase from 2,789,506,992.52 RMB year-over-year, reflecting improved investment recovery[55] - The net cash flow from financing activities was 4,752,936,966.84 RMB, up from 4,028,851,454.62 RMB in the previous year, showing stronger financing capabilities[58] - The cash outflow for operating activities was 17,907,432,306.31 RMB, compared to 13,931,344,243.11 RMB in the previous year, indicating increased operational costs[55] Shareholder Information - The total number of shareholders at the end of the reporting period was 63,389[17] - The largest shareholder, China National Chemical Corporation, holds 54.18% of the shares[17] - The company's equity attributable to shareholders increased to ¥13,240,910,423.60 from ¥12,959,353,124.15, a rise of about 2.2%[35] - The total equity of the company reached ¥28,849,555,373.94, compared to ¥28,000,292,289.41, marking an increase of approximately 3.0%[35] Inventory and Receivables - Accounts receivable increased by 58.57% to ¥6,462,174,476.48 from ¥4,075,353,728.70 due to increased sales[20] - Inventory increased by 31.93% to ¥8,649,893,711.67 from ¥6,556,547,479.87, driven by sales growth and increased stocking[20] - The company reported a significant increase in other receivables, which rose by 365.99% to ¥3,369,573,164.01 from ¥723,094,361.44 due to payments for equity transaction deposits[20] - Other income increased by 63.64% to ¥37,915,328.96 from ¥23,169,589.02 due to higher government subsidies[23] Research and Development - Research and development expenses for Q1 2021 amounted to ¥223,415,726.06, compared to ¥179,793,716.96 in Q1 2020, showing an increase of approximately 24.2%[44] - The company's research and development expenses for Q1 2021 were ¥6,222,546.17, slightly up from ¥5,984,183.90 in Q1 2020[51] Government Subsidies and Other Income - The company reported a government subsidy of CNY 37,915,328.96 during the period[16] - The company reported a significant increase in other income, totaling ¥8,704,138.84 in Q1 2021, compared to ¥5,030,860.50 in Q1 2020[51]